Prevalence and Prognostic Importance of High Fibrosis‐4 Index in COVID‐19 Patients
Open Access
- 1 January 2022
- journal article
- research article
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 2022 (1) , 1734896
Abstract
Introduction. The fibrosis 4 (FIB‐4) index was developed to predict advanced fibrosis in patients with liver disease. We aimed to evaluate the association of FIB‐4 with risk factors for progression to critical illness in middle‐aged patients hospitalized for coronavirus disease 2019 (COVID‐19). Method. We included patients aged 35–65 years who were hospitalized following a positive RT‐PCR SARS‐Cov‐2 test in a tertiary hospital. All data were obtained from the medical records of the patients during the first admission to the hospital. The FIB‐4 index was calculated according to the equation (age (years) x AST (IU/L)/platelet count (109/L)/√ALT (IU/L)). The FIB‐4 index was divided into three categories according to the score categorisation: 2.67 = high risk. Results. A total of 619 confirmed COVID‐19 patients (mean age = 52 yrs.) were included in this study; 37 (6.0%) were admitted to the intensive care unit (ICU), of which 44% were intubated and eight (1.3%) patients died during follow‐up. The results of patients with high FIB‐4 scores were compared with those with low FIB‐4 scores. In patients with high FIB‐4 scores, male gender, and advanced age, decreased neutrophil, lymphocyte, thrombocyte, and albumin counts, elevated AST, LDH, CK, ferritin, CRP, and D‐dimer, and low GFR were the high‐risk factors for critical illness. Additionally, the number of patients referred to ICU with high FIB‐4 who died had higher scores than from those with low scores. Conclusion. The FIB‐4 index derived from baseline data obtained during hospitalisation can be used as a simple, inexpensive, and straightforward indicator to predict ICU requirement and/or death in middle‐aged hospitalized COVID‐19 patients.Keywords
This publication has 33 references indexed in Scilit:
- Impact of the Fibrosis-4 Index on Risk Stratification of Cardiovascular Events and Mortality in Patients with Atrial Fibrillation: Findings from a Japanese Multicenter RegistryJournal of Clinical Medicine, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmissionScience China Life Sciences, 2020
- Liver Fibrosis, Not Steatosis, Associates with Long-Term Outcomes in Ischaemic Stroke PatientsCerebrovascular Diseases, 2019
- Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD FibrosisAmerican Journal of Gastroenterology, 2017
- Screening for liver fibrosis in the general population: a call for actionThe Lancet Gastroenterology & Hepatology, 2016
- Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaborationInternational Journal of Surgery, 2014
- Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver DiseaseClinical Gastroenterology and Hepatology, 2009
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionHepatology, 2006
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004